首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1819729

2021-2031 年北美解剖病理学市场报告（范围、细分、动态和竞争分析）

North America Anatomic Pathology Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年07月10日 | 出版商:

The Insight Partners | 英文 127 Pages | 订单完成后即时交付

价格

简介目录图表

解剖病理学市场预计将大幅成长，到 2031 年将达到约 213.9845 亿美元，高于 2023 年的 126.9248 亿美元。这一成长代表着 2023 年至 2031 年的年复合成长率(CAGR) 为 6.7%。

执行摘要和北美解剖病理学市场概览

在北美，解剖病理学市场主要分为三个区域：美国、加拿大和墨西哥。该地区被认为是解剖病理学领域的主要参与者，这主要得益于该地区癌症发病率的上升、政府加强癌症筛检倡议、对精准疾病诊断的日益重视以及对先进医疗保健系统的需求不断增长。此外，预计该市场将受益于主要产业参与者加强的研发活动以及新产品的推出，这些活动预计将在整个预测期内推动北美解剖病理学市场的成长。

北美解剖病理学市场細項分析

北美解剖病理学市场的分析基于几个关键部分，包括产品和服务、应用和最终用户。

1. 产品与服务：市场分为服务、仪器和耗材。 2023年，仪器占据了最大的市场。服务细分市场进一步分为组织病理学和细胞病理学，而仪器细分市场包括切片机、低温恆温器、自动染色机、组织处理机和其他相关工具。

2. 应用：市场按应用细分为疾病诊断、药物研发和其他领域。疾病诊断领域在2023年占据最大份额，反映了解剖病理学在识别各种疾病方面的关键作用。

3. 最终使用者：最终使用者细分包括医院、研究实验室、诊断实验室等。医院在2023年占据了最大的市场份额，凸显了其在提供解剖病理学服务方面的核心作用。

北美解剖病理学市场展望

在解剖病理学市场中，无论规模大小，越来越多的公司正在实施各种策略，例如地理扩张、推出新产品以及技术进步，以增强收入来源。市场近期发展包括：

2024年5月：Quest Diagnostics与PathAI宣布合作，旨在加速数位和AI病理学创新的整合，以提高癌症和疾病诊断的品质、速度和效率。作为该协议的一部分，Quest将从PathAI Diagnostics收购特定资产，PathAI Diagnostics专注于数位和解剖病理学实验室服务。
2024年4月：Medline成为PHC集团旗下Epredia的经销商，Epredia则为解剖病理学领域提供精准癌症诊断与组织诊断解决方案。此次合作使Medline能够扩展其实验室产品和设备组合。
2024年4月：StatLab Medical Products收购了总部位于芝加哥的Scientific Device Laboratory，后者专门生产用于解剖病理学和微生物学的诊断玻片及耗材。此次收购增强了StatLab的製造能力和市场影响力。
2024 年 2 月：Hologic Inc 的 Genius 数位诊断系统获得 FDA 批准，这是一款专为巴氏抹片检查设计的尖端数位细胞学系统，预计将于 2024 年在欧洲、澳洲和纽西兰上市后在美国推出。

市场参与者的这些策略倡议预计将对解剖病理学市场的成长做出重大贡献。

北美解剖病理学市场国家洞察

北美解剖病理学市场主要由美国、加拿大和墨西哥组成，其中美国在2023年占据最大市场份额。癌症仍然是美国主要的公共卫生问题，常见癌症类型包括乳癌、肺癌、摄护腺癌、结肠癌和肝癌。根据美国国家癌症研究所的数据，截至2021年，美国约有1,743万人患有癌症，预计到2030年，癌症倖存者的数量可能达到2,220万人。癌症盛行率的上升预计将推动对各种病理诊断测试的需求，包括活检、细针穿刺、基因检测和其他创新技术。

此外，美国医疗技术取得了显着进步，推动了医疗保健领域先进医疗器材的开发。美国解剖病理学市场的公司专注于为病理学程序开发创新且用户友好的仪器和耗材。例如，2023年11月，Illumina公司推出了其液体活检检测的新版本TruSight Oncology 500 ctDNA v2，该检测可以对血液样本中的循环肿瘤DNA进行全面的非侵入性基因组分析，补充了传统的组织检测。 2020年，罗氏公司获得FDA核准，扩大CINtec PLUS细胞学检测的用途，以辅助预防子宫颈癌。

这些因素，包括癌症高发病率、主要行业参与者的存在以及医院和临床实验室的高品质基础设施，预计将进一步促进美国解剖病理学市场的成长。

北美解剖病理学市场公司简介

北美解剖病理学市场的主要参与者包括罗氏公司（F. Hoffmann-La Roche Ltd）、贝克曼库尔特公司（Beckman Coulter Inc）、豪洛捷公司（Hologic Inc）、安捷伦科技公司（Agilent Technologies Inc）、BioGenex Laboratories Inc、Diapath SpA、Bio 公司（Agilent Technologies Inc）、BioGenex Laboratories Inc、Diapath SpA、Bio 、默克公司（Merck K HoldingsA）。这些公司正在积极推行市场扩张、产品创新和併购等策略，以增强产品组合併提高市场份额。

In North America, the anatomic pathology market is divided into three main regions: the United States, Canada, and Mexico. This region is recognized as a major player in the anatomic pathology sector, primarily due to the increasing incidence of cancer, enhanced government initiatives aimed at cancer screening, a growing emphasis on accurate disease diagnosis, and the rising demand for advanced healthcare systems. Additionally, the market is expected to benefit from heightened research and development activities by key industry players, along with the introduction of new products, which are anticipated to propel the growth of the anatomic pathology market in North America throughout the forecast period.

North America Anatomic Pathology Market Segmentation Analysis

The analysis of the North American anatomic pathology market is based on several key segments, including products and services, applications, and end users.

1. Products and Services: The market is categorized into services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is segmented by application into disease diagnosis, drug discovery and development, and other areas. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various diseases.

3. End Users: The end-user segmentation includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in the delivery of anatomic pathology services.

North America Anatomic Pathology Market Outlook

Companies, both large and small, operating within the anatomic pathology market are increasingly implementing various strategies such as geographic expansion, launching new products, and advancing technology to enhance their revenue streams. Recent developments in the market include:

May 2024: Quest Diagnostics and PathAI announced a collaboration aimed at accelerating the integration of digital and AI pathology innovations to enhance the quality, speed, and efficiency of cancer and disease diagnoses. As part of this agreement, Quest will acquire specific assets from PathAI Diagnostics, which specializes in digital and anatomic pathology laboratory services.
April 2024: Medline became the distributor for Epredia, a member of the PHC Group, which offers solutions for precision cancer diagnostics and tissue diagnostics in the anatomic pathology sector. This partnership allows Medline to expand its portfolio of laboratory products and equipment.
April 2024: StatLab Medical Products acquired Scientific Device Laboratory, a Chicago-based manufacturer of diagnostic slides and consumables for anatomic pathology and microbiology. This acquisition enhances StatLab's manufacturing capabilities and market presence.
February 2024: Hologic Inc received FDA approval for its Genius Digital Diagnostics System, a cutting-edge digital cytology system designed for pap testing, which is set to launch in the US in 2024 after being available in Europe, Australia, and New Zealand.

These strategic initiatives by market players are expected to significantly contribute to the growth of the anatomic pathology market.

North America Anatomic Pathology Market Country Insights

The North American anatomic pathology market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2023. Cancer remains a major public health concern in the US, with prevalent types including breast, lung, prostate, colon, and liver cancers. According to the National Cancer Institute, approximately 17.43 million individuals were living with cancer in the US as of 2021, with projections indicating that the number of cancer survivors could reach 22.2 million by 2030. This increasing prevalence of cancer is expected to drive demand for various pathologic diagnostic tests, including biopsies, fine-needle aspirations, genetic testing, and other innovative techniques.

Moreover, the US has witnessed remarkable advancements in medical technologies, leading to the development of sophisticated medical devices within the healthcare sector. Companies in the US anatomic pathology market are focused on creating innovative and user-friendly instruments and consumables for pathological procedures. For instance, in November 2023, Illumina Inc. launched a new version of its liquid biopsy assay, TruSight Oncology 500 ctDNA v2, which allows for comprehensive noninvasive genomic profiling of circulating tumor DNA from blood samples, complementing traditional tissue-based testing. In 2020, F. Hoffmann-La Roche received FDA approval for the expanded use of the CINtec PLUS Cytology test, aiding in cervical cancer prevention.

These factors, including the high cancer prevalence, the presence of major industry players, and the availability of high-quality infrastructure for hospitals and clinical laboratories, are expected to further bolster the growth of the anatomic pathology market in the US.

North America Anatomic Pathology Market Company Profiles

Key players in the North American anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market share.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. North America Anatomic Pathology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.1.2 Rise in Number of Strategic Initiatives
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
- 5.3.1 Growing Focus on Personalized Medicines
5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence and Machine Learning
5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - North America Analysis

6.1 North America Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 North America Anatomic Pathology Market Forecast Analysis

7. North America Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Anatomic Pathology Market - Country Analysis

10.1 North America
- 10.1.1 North America Anatomic Pathology Market Overview
- 10.1.2 North America Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 United States: North America Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.1.1.1 United States: North America Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.1.1.2 United States: North America Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.1.2 United States: North America Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.1.3 United States: North America Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.2 Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Canada: North America Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.2.1.1 Canada: North America Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.2.1.2 Canada: North America Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.2.2 Canada: North America Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.2.3 Canada: North America Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.3 Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 Mexico: North America Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.3.1.1 Mexico: North America Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.3.1.2 Mexico: North America Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.3.2 Mexico: North America Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.3.3 Mexico: North America Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in North America Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Diapath S.p.A.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio SB
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Merck KGaA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 PHC Holdings Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Anatomic Pathology Market Segmentation
Table 2. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Product and Services
Table 4. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 7. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 8. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 9. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 11. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 12. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 13. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 14. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 16. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 17. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 18. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 19. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 21. Recent Organic Growth Strategies in North America Anatomic Pathology Market
Table 22. Recent Inorganic Growth Strategies in the North America Anatomic Pathology Market
Table 23. Glossary of Terms, North America Anatomic Pathology Market

List Of Figures

Figure 1. North America Anatomic Pathology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. North America Anatomic Pathology Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Anatomic Pathology Market Revenue (US$ Million), 2021-2031
Figure 6. North America Anatomic Pathology Market Share (%) - by Product and Services (2023 and 2031)
Figure 7. Services: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Instruments: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Consumables: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. North America Anatomic Pathology Market Share (%) - by Application (2023 and 2031)
Figure 11. Disease Diagnosis: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Drug Discovery and Development: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. North America Anatomic Pathology Market Share (%) - by End User (2023 and 2031)
Figure 15. Hospitals: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Research Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. North America Anatomic Pathology Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
Figure 20. North America Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in North America Anatomic Pathology Market